Blog

Industry report – IP trend evaluation – CAR T-cell therapy – IAM (blog)


IAM (blog)

Industry report – IP trend evaluation – CAR T-cell therapy
IAM (blog)
Chimeric antigen receptor (CAR) T-cell therapy is transforming the way that cancer is treated. It is an innovative immunotherapy treatment which uses patients' immune cells to target tumours. Chemotherapy and radiation therapy have long been the major

2018-03-21 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.